Fig. 1From: Predicting analysis times in randomized clinical trials with cancer immunotherapyEvent-free survival by mechanisms of action. a Treatment effects measured by time to event endpoint when patients receive therapies with different mechanisms of action (i.e., cancer immunotherapy, targeted therapy, and chemotherapy). b Corresponding hazard functions (i.e., risk of event of interest)Back to article page